中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共10条,第1-10条 帮助

条数/页: 排序方式:
Design, synthesis and pharmacological evaluation of 1,2,3,4-tetrahydrobenzofuro[2,3-c] pyridine derivatives as p21-activated kinase 4 inhibitors for treatment of pancreatic cancer 期刊论文  OAI收割
ACTA PHARMACEUTICA SINICA B, 2025, 卷号: 15, 期号: 1, 页码: 438-466
作者:  
Li, Yang;  Fang, Yan;  Chen, Xiaoyu;  Tong, Linjiang;  Feng, Fang
  |  收藏  |  浏览/下载:12/0  |  提交时间:2025/04/01
Design and synthesis of pyridazin-4-one derivatives as necroptosis inhibitors 期刊论文  OAI收割
ARCHIV DER PHARMAZIE, 2024, 页码: 16
作者:  
  |  收藏  |  浏览/下载:12/0  |  提交时间:2024/12/25
Discovery and optimization of thieno[3,2-d]pyrimidine derivatives as highly selective inhibitors of cyclin-dependent kinase 7 期刊论文  OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 263, 页码: 21
作者:  
Zhang, Hongjin;  Lin, Guohao;  Jia, Suyun;  Zhang, Ying;  Wu, Jianbo
  |  收藏  |  浏览/下载:15/0  |  提交时间:2024/01/26
Discovery of pseudolaric acid A as a new Hsp90 inhibitor uncovers its potential anticancer mechanism 期刊论文  OAI收割
BIOORGANIC CHEMISTRY, 2021, 卷号: 112, 页码: 104963
作者:  
Liu,Jiangxin;  Wu,Xing-De;  Li,Wenyan;  Yuan,Zaifeng;  Yang,Kun
  |  收藏  |  浏览/下载:26/0  |  提交时间:2022/04/02
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent 期刊论文  OAI收割
ACTA PHARMACEUTICA SINICA B, 2020, 卷号: 10
作者:  
Jiang, Zongru;  Wang, Li;  Liu, Xuesong;  Chen, Cheng;  Wang, Beilei
  |  收藏  |  浏览/下载:60/0  |  提交时间:2020/11/26
Discovery of (R)-5-((5-(1-methyl-1H-pyrazol-4-yl)-4-(methylamino) pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies 期刊论文  OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 173, 页码: 44-62
作者:  
Tong, Lexian;  Song, Pinrao;  Jiang, Kailong;  Xu, Lei;  Jin, Tingting
  |  收藏  |  浏览/下载:31/0  |  提交时间:2020/07/01
Discovery of a series of dimethoxybenzene FGFR inhibitors with 5H-pyrrolo[2,3-b]pyrazine scaffold: structure-activity relationship, crystal structural characterization and and in vivo study 期刊论文  OAI收割
ACTA PHARMACEUTICA SINICA B, 2019, 卷号: 9, 期号: 2, 页码: 351-368
作者:  
Wei, Peng;  Liu, Bo;  Wang, Ruifeng;  Gao, Yinglei;  Li, Lanlan
  |  收藏  |  浏览/下载:52/0  |  提交时间:2020/07/01
Identification of hydrazone moiety-bearing aminopyrimidines as potent antitumor agents with selective inhibition of gefitinib-resistant H1975 cancer cells 期刊论文  OAI收割
CHINESE CHEMICAL LETTERS, 2017, 卷号: 28, 期号: 5, 页码: 991-994
作者:  
Qin MingZe;  Wang Lei;  Yan Shuang;  Ma JunJie;  Tian Ye
  |  收藏  |  浏览/下载:49/0  |  提交时间:2021/02/02
Identification of hydrazone moiety-bearing aminopyrimidines as potent antitumor agents with selective inhibition of gefitinib-resistant H1975 cancer cells 期刊论文  OAI收割
CHINESE CHEMICAL LETTERS, 2017, 卷号: 28, 期号: 5, 页码: 991-994
作者:  
Qin MingZe;  Wang Lei;  Yan Shuang;  Ma JunJie;  Tian Ye
  |  收藏  |  浏览/下载:52/0  |  提交时间:2021/02/02
O-Linked Triazolotriazines: Potent and Selective c-Met Inhibitors 期刊论文  OAI收割
CHEMMEDCHEM, 2012, 卷号: 7, 期号: 7, 页码: 1276-1285
作者:  
Chen, Fang;  Wang, Ying;  Ai, Jing;  Zhan, Zhengsheng;  Lv, Yongcong
  |  收藏  |  浏览/下载:9/0  |  提交时间:2019/01/08